DSC1 and colorectal carcinoma: In both classifications, high expression of DSC1 was associated with unfavorable outcome in the highly aggressive mesenchymal subtypes, CMS4 and CRIS-B, supporting a correlation between high expression of DSC1 and the mesenchymal, invasive CRC subtypes (Fig. S4).